178 related articles for article (PubMed ID: 20025731)
1. Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer.
Xia P; An HX; Dang CX; Radpour R; Kohler C; Fokas E; Engenhart-Cabillic R; Holzgreve W; Zhong XY
BMC Cancer; 2009 Dec; 9():454. PubMed ID: 20025731
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA levels in blood and tissue samples from breast cancer patients of different stages.
Xia P; Wang HJ; Geng TT; Xun XJ; Zhou WJ; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(3):1339-44. PubMed ID: 24606462
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer.
Fan AX; Radpour R; Haghighi MM; Kohler C; Xia P; Hahn S; Holzgreve W; Zhong XY
J Cancer Res Clin Oncol; 2009 Aug; 135(8):983-9. PubMed ID: 19125299
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma.
Lin CS; Chang SC; Ou LH; Chen CM; Hsieh SS; Chung YP; King KL; Lin SL; Wei YH
Oncol Rep; 2015 Jun; 33(6):2924-34. PubMed ID: 25845386
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood mitochondrial DNA content, A10398G polymorphism, and risk of breast cancer in a Han Chinese population.
Jiang H; Zhao H; Xu H; Hu L; Wang W; Wei Y; Wang Y; Peng X; Zhou F
Cancer Sci; 2014 Jun; 105(6):639-45. PubMed ID: 24703408
[TBL] [Abstract][Full Text] [Related]
6. Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.
Kohler C; Radpour R; Barekati Z; Asadollahi R; Bitzer J; Wight E; Bürki N; Diesch C; Holzgreve W; Zhong XY
Mol Cancer; 2009 Nov; 8():105. PubMed ID: 19922604
[TBL] [Abstract][Full Text] [Related]
7. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantitative assessment of circulating cell-free mitochondrial and nuclear DNA by multiplex real-time PCR.
Xia P; Radpour R; Zachariah R; Fan AX; Kohler C; Hahn S; Holzgreve W; Zhong XY
Genet Mol Biol; 2009 Jan; 32(1):20-4. PubMed ID: 21637641
[TBL] [Abstract][Full Text] [Related]
9. Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients.
Mahmoud EH; Fawzy A; Ahmad OK; Ali AM
Asian Pac J Cancer Prev; 2015; 16(18):8299-305. PubMed ID: 26745076
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
[TBL] [Abstract][Full Text] [Related]
11. A decreased mitochondrial DNA content is related to insulin resistance in adolescents.
Gianotti TF; Sookoian S; Dieuzeide G; García SI; Gemma C; González CD; Pirola CJ
Obesity (Silver Spring); 2008 Jul; 16(7):1591-5. PubMed ID: 18451773
[TBL] [Abstract][Full Text] [Related]
12. Platelets, a typical source of error in real-time PCR quantification of mitochondrial DNA content in human peripheral blood cells.
Banas B; Kost BP; Goebel FD
Eur J Med Res; 2004 Aug; 9(8):371-7. PubMed ID: 15337626
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood mitochondrial DNA/nuclear DNA (mtDNA/nDNA) ratio as a marker of mitochondrial toxicities of stavudine containing antiretroviral therapy in HIV-infected Malawian patients.
Kampira E; Dzobo K; Kumwenda J; van Oosterhout JJ; Parker MI; Dandara C
OMICS; 2014 Jul; 18(7):438-45. PubMed ID: 24816082
[TBL] [Abstract][Full Text] [Related]
14. Higher peripheral blood mitochondrial DNA copy number and relative telomere length in under 48 years Indonesian breast cancer patients.
Limardi PC; Panigoro SS; Siregar NC; Sutandyo N; Witjaksono F; Priliani L; Oktavianthi S; Malik SG
BMC Res Notes; 2024 Apr; 17(1):120. PubMed ID: 38679744
[TBL] [Abstract][Full Text] [Related]
15. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
Zheng HY; Chen Q; Ye YB; Huang WW
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.
Ellinger J; Müller SC; Wernert N; von Ruecker A; Bastian PJ
BJU Int; 2008 Aug; 102(5):628-32. PubMed ID: 18410441
[TBL] [Abstract][Full Text] [Related]
17. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
[TBL] [Abstract][Full Text] [Related]
18. Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer.
Keserű JS; Soltész B; Lukács J; Márton É; Szilágyi-Bónizs M; Penyige A; Póka R; Nagy B
J Biotechnol; 2019 Jun; 298():76-81. PubMed ID: 31002856
[TBL] [Abstract][Full Text] [Related]
19. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors.
Moazzezy N; Ebrahimi F; Sisakht MM; Yahyazadeh H; Bouzari S; Oloomi M
Asian Pac J Cancer Prev; 2016; 17(1):249-54. PubMed ID: 26838218
[TBL] [Abstract][Full Text] [Related]
20. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
